Grégoire Altan-Bonnet

National Cancer Institute, Rockville, MD, United States 
Systems Immunology
"Grégoire Altan-Bonnet"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Gaud G, Achar S, Bourassa FXP, et al. (2023) CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides. Nature Immunology
Chan W, Cao YM, Zhao X, et al. (2023) TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathways. The Journal of Experimental Medicine. 220
Sanchez EE, Tello-Lafoz M, Guo AJ, et al. (2023) Apoptotic contraction drives target cell release by cytotoxic T cells. Nature Immunology
Anibal J, Day AG, Bahadiroglu E, et al. (2022) HAL-X: Scalable hierarchical clustering for rapid and tunable single-cell analysis. Plos Computational Biology. 18: e1010349
Achar SR, Bourassa FXP, Rademaker TJ, et al. (2022) Universal antigen encoding of T cell activation from high-dimensional cytokine dynamics. Science (New York, N.Y.). 376: 880-884
Chin SS, Guillen E, Chorro L, et al. (2022) T cell receptor and IL-2 signaling strength control memory CD8 T cell functional fitness via chromatin remodeling. Nature Communications. 13: 2240
Wong HS, Park K, Gola A, et al. (2021) A local regulatory T cell feedback circuit maintains immune homeostasis by pruning self-activated T cells. Cell
Ghosh S, Dellibovi-Ragheb TA, Kerviel A, et al. (2020) β-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway. Cell
Masih KE, Gardner R, Gryder BE, et al. (2020) Abstract A11: A comprehensive and integrative omic analysis of multiply relapsed refractory pediatric pre-B cell acute lymphoblastic leukemia predicts response to CD19 CAR T-cell therapy Cancer Research. 80
Masih KE, Abdelmaksoud A, Milewski D, et al. (2020) Abstract LB-141: Increased epigenetic plasticity and tumor heterogeneity predict resistance to CD19 CAR T cell therapy in pre-treatment pediatric acute lymphoblastic leukemia Cancer Research. 80
See more...